News
By Deena Beasley (Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' ...
6h
Stocktwits on MSNCVS Health Reportedly Keeps Gilead’s New HIV Preventative Shot Off Its Plans, Faces $290M Medicare Fraud Ruling
CVS Health, which operates the largest U.S. pharmacy benefit manager, will not add Gilead Sciences’ new HIV prevention drug ...
Investing.com -- CVS Health (NYSE: CVS) will not include Gilead Sciences (NASDAQ: GILD )’ new HIV prevention drug Yeztugo in its commercial plans for the time being, despite the medication’s proven ...
Dividend Growth: CVS has increased its dividend by 142% over the past decade, with a current forward yield of 4.64%. This significantly surpasses the S&P 500 average of 1.35%.
In Gilead’s case, a CVS spokesperson declined to confirm payment of a discount for its preferential formulary treatment, which is being made available for treating patients with all HCV genotypes, in ...
CVS to Exclusively Distribute Gilead Sciences's $1,000-Per-Pill Hepatitis C Treatment Published Jan 06, 2015 at 5:02 PM EST Updated Mar 12, 2016 at 9:16 AM EST ...
The battle for supremacy in one of the fastest-growing pharmaceutical markets intensified on Monday, with CVS Health Corp. saying it will make Gilead Sciences Inc.’s drugs Sovaldi and Harvoni ...
Gilead Sciences agreed to make its hepatitis C medicines the exclusive treatments for CVS Health customers, intensifying a drug-industry rivalry to win patients for the $1,000-a-day medicines.
CVS said the Gilead drugs would be exclusive on its standard commercial formulary, as well as those for exchanges created under the Affordable Care Act, Medicare Part D and Medicaid.
CVS Health announced Monday that it plans to make Gilead Sciences' hepatitis C drugs the exclusive option for most of its consumers starting Wednesday. January 06, 2015 • Tribune News Service ...
CVS Health Corp, one of the largest U.S. managers of drug benefits, said it would give preferred status to the hepatitis C treatments from Gilead Sciences and cover a new competing treatment from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results